Purchase Order 75N91021P00931
- Not listed
- The Department of Health and Human Services National Institutes of Health (NIH) Clinical Center awarded a firm-fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for preventative maintenance of four CliniMACS Prodigy and five CliniMACS Plus cell processing instruments used in the Center for Cellular Engineering's cell therapy production facility. The $112,267 contract provides maintenance services from May 10, 2021 through September 23, 2022 to...
- The National Institutes of Health Clinical Center awarded a purchase order to Miltenyi Biotec, Inc. for a CliniMACS Prodigy Instrument, operational qualification, and training on June 28, 2021, with a firm fixed-price ceiling value of $252,809.50 and ultimate completion date of July 15, 2021. Performance takes place in Auburn, California. The procured CliniMACS Prodigy is a proprietary, closed automated system for manufacturing cell-based therapies to support multiple clinical trials at the...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) Clinical Center awarded a $158,220 firm-fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for the delivery and installation qualification of two CliniMACS Plus instruments. The purchase supports the NIH Clinical Center's Center for Cellular Engineering, an AABB-accredited cell therapy laboratory that provides manufacturing services for over 50 intramural clinical...
- The Department of Health and Human Services National Institutes of Health National Cancer Institute awarded a $210,208 firm fixed price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, to procure a "BRAND NAME OR EQUAL MACSQUANT ANALYZER 16 DIGITAL BENCHTOP FLOW CYTOMETER AND AUTOMACS PRO SEPARATOR - STARTER KIT". This requirement was not set aside for any small business program. The award was based on a pre-solicitation sources sought notice that...
- This $142,174 firm-fixed-price purchase order was awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company that specializes in cell separation, analysis, and processing technologies. The contract is for the supply of CliniMACS Prodigy Essential Service Units to support the NIH Clinical Center's cell therapy manufacturing capabilities. This award is part of a larger $2.3 million indefinite delivery contract (IDC) that Miltenyi...
- The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute awarded a $120,526.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer, for the acquisition of a Miltenyi MACSQuant 10 Analyzer. The equipment will be used at the NIH campus in Bethesda, Maryland. Miltenyi Biotec has extensive experience providing scientific instruments, reagents, and cell therapy manufacturing platforms to federal...
- This is a firm fixed-price purchase order contract awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc., a foreign-owned, for-profit manufacturer of scientific instruments, reagents, and services for biomedical research and cell therapy development. The contract, valued at $18,897.00, is for the provision of a MACS (Magnetic Cell Separation) AutoMACS Pro Separator, which is a specialized cell separation...
- The U.S. National Institutes of Health (NIH) Clinical Center awarded a $71,087 firm fixed-price purchase order to Miltenyi Biotec, Inc. to provide preventative maintenance services for the agency's CliniMACS Prodigy cell processing instruments through June 1, 2026. This contract does not have a set-aside designation. Miltenyi Biotec is a global manufacturer of biomedical research and cell therapy products, including the CliniMACS line of automated cell isolation systems used by the NIH's Cell...
- <p>The NIH Clinical Center awarded a purchase order to Miltenyi Biotec, Inc. for full service support of CliniMACS Prodigy equipment with a ceiling value of $17,507.00, awarded May 20, 2020, with ultimate completion by May 27, 2021. Work is performed in Auburn, California. This is a firm fixed-price, non-competitive procurement reflecting the vendor's sole-source position in specialized cell isolation and processing systems. No small business set-aside was used.</p>
- This is a $312,065 firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Miltenyi Biotec, Inc., a global biotechnology company specializing in cell therapy products and instruments. The contract provides for the delivery and installation of specialized laboratory equipment such as CliniMACS Prodigy cell processing systems, MACSQuant flow cytometers, and GentleMACS tissue dissociators, as well as proprietary cell isolation reagents and...
The Department of Health and Human Services' National Institutes of Health (NIH) National Cancer Institute awarded a purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, to acquire a Miltenyi ClinicMACS Prodigy device for $249,369.00. The Prodigy is an automated, closed-system cell processing instrument that will support preclinical and translational studies of novel cell therapies within the NIH's Pediatric Oncology Branch and Center for Cellular Engineering. This sole-source acquisition was made under simplified procedures for commercial items, without a set-aside designation, and will enable the NIH to increase compliance with FDA regulations, reduce operational costs, and accelerate the development of cell-based cancer therapies for patients enrolled in NIH-sponsored clinical trials.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
Miltenyi ClinicMACS Prodigy | 75N91021Q00258 | Department of Health and Human Services National Institutes of Health National Cancer Institute | Special Notice 1/1 | 8/25/21, 12:13 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $249.4k | 9/24/21 |